Summit Therapeutics Overview
Summit Therapeutics Target Price
Analysts' 12-month price predictions for SMMT.
Share Price
$25.98
Average Target Price
$21.00
19.2% downside
19.2% downside1 analysts in the last 4 months
High: $21 | Low: $21
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-19 | Summit Redstone PartnersKelsey Goodwin | $21 | 19.2% downside |  |
| 2025-04-28 | H.C. Wainwright | $44 |  69.4% upside | |
| 2025-04-25 | Wells Fargo | $30 | 15.5% upside | |
| 2025-04-25 | JefferiesKelly Shi | $44 | 69.4% upside | |
| 2025-03-26 | Summit Redstone PartnersYigal Nochomovitz | $35 | 34.7% upside | |
| 2025-02-28 | Summit Redstone Partners | $42 | 61.7% upside | |
| 2024-11-04 | JMP SecuritiesReni Benjamin | $32 | 23.2% upside | |
| 2024-09-27 | Summit Redstone PartnersYigal Nochomovitz | $23 | 11.5% downside | |
| 2024-09-25 | Stifel NicolausBrad Canino | $40 | 54% upside | |
| 2024-09-16 | H.C. WainwrightMitchell Kapoor | $45 | 73.2% upside | |
| 2024-06-03 | Stifel NicolausBrad Canino | $14 | 46.1% downside | |
| 2024-03-25 | Stifel NicolausBrad Canino | $8 | 69.2% downside | |